These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 35870552)
1. Serum fatty acid profiling in patients with SDHx mutations: New advances on cellular metabolism in SDH deficiency. Vamecq J; Masso V; Bancel LP; Jannin A; Dessein AF; Cardot-Bauters C; Pigny P Biochimie; 2022 Oct; 201():196-203. PubMed ID: 35870552 [TBL] [Abstract][Full Text] [Related]
2. Serum Succinate/Fumarate Ratio in Patients With Paraganglioma/Pheochromocytoma Attending an Endocrine Oncogenetic Unit. Bancel LP; Masso V; Dessein AF; Aubert S; Leteurtre E; Coppin L; Odou MF; Cao CD; Cardot-Bauters C; Pigny P J Clin Endocrinol Metab; 2023 Aug; 108(9):2343-2352. PubMed ID: 36848172 [TBL] [Abstract][Full Text] [Related]
3. Risk of metastatic pheochromocytoma and paraganglioma in Lee H; Jeong S; Yu Y; Kang J; Sun H; Rhee JK; Kim YH J Med Genet; 2020 Apr; 57(4):217-225. PubMed ID: 31649053 [TBL] [Abstract][Full Text] [Related]
4. In Vivo Detection of Succinate by Magnetic Resonance Spectroscopy as a Hallmark of SDHx Mutations in Paraganglioma. Lussey-Lepoutre C; Bellucci A; Morin A; Buffet A; Amar L; Janin M; Ottolenghi C; Zinzindohoué F; Autret G; Burnichon N; Robidel E; Banting B; Fontaine S; Cuenod CA; Benit P; Rustin P; Halimi P; Fournier L; Gimenez-Roqueplo AP; Favier J; Tavitian B Clin Cancer Res; 2016 Mar; 22(5):1120-9. PubMed ID: 26490314 [TBL] [Abstract][Full Text] [Related]
5. Succinate: A Serum Biomarker of SDHB-Mutated Paragangliomas and Pheochromocytomas. Lamy C; Tissot H; Faron M; Baudin E; Lamartina L; Pradon C; Al Ghuzlan A; Leboulleux S; Perfettini JL; Paci A; Hadoux J; Broutin S J Clin Endocrinol Metab; 2022 Sep; 107(10):2801-2810. PubMed ID: 35948272 [TBL] [Abstract][Full Text] [Related]
6. Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency. Richter S; Peitzsch M; Rapizzi E; Lenders JW; Qin N; de Cubas AA; Schiavi F; Rao JU; Beuschlein F; Quinkler M; Timmers HJ; Opocher G; Mannelli M; Pacak K; Robledo M; Eisenhofer G J Clin Endocrinol Metab; 2014 Oct; 99(10):3903-11. PubMed ID: 25014000 [TBL] [Abstract][Full Text] [Related]
7. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma. Bayley JP; Bausch B; Rijken JA; van Hulsteijn LT; Jansen JC; Ascher D; Pires DEV; Hes FJ; Hensen EF; Corssmit EPM; Devilee P; Neumann HPH J Med Genet; 2020 Feb; 57(2):96-103. PubMed ID: 31492822 [TBL] [Abstract][Full Text] [Related]
8. Clinical implications of the oncometabolite succinate in SDHx-mutation carriers. Eijkelenkamp K; Osinga TE; Links TP; van der Horst-Schrivers ANA Clin Genet; 2020 Jan; 97(1):39-53. PubMed ID: 30977114 [TBL] [Abstract][Full Text] [Related]
9. SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma. Menara M; Oudijk L; Badoual C; Bertherat J; Lepoutre-Lussey C; Amar L; Iturrioz X; Sibony M; Zinzindohoué F; de Krijger R; Gimenez-Roqueplo AP; Favier J J Clin Endocrinol Metab; 2015 Feb; 100(2):E287-91. PubMed ID: 25405498 [TBL] [Abstract][Full Text] [Related]
10. The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. Bayley JP; Devilee P; Taschner PE BMC Med Genet; 2005 Nov; 6():39. PubMed ID: 16288654 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours. Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741 [TBL] [Abstract][Full Text] [Related]